722 related articles for article (PubMed ID: 19515046)
1. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
3. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
4. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
5. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
6. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
8. Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study.
Tucci MG; Offidani A; Lucarini G; Simonelli L; Amati S; Cellini A; Biagini G; Ricotti G
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):118-24. PubMed ID: 9553907
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
10. [Nuclear DNA analysis of benign skin tumor and carcinoma in site developed from keratinocyte].
Toyoshima H; Hori M; Yoshida H
Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):527-31. PubMed ID: 1890748
[TBL] [Abstract][Full Text] [Related]
11. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
Wrone DA; Yoo S; Chipps LK; Moy RL
Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
[TBL] [Abstract][Full Text] [Related]
12. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2.
Chen SJ; Nakahara T; Takahara M; Kido M; Dugu L; Uchi H; Takeuchi S; Tu YT; Moroi Y; Furue M
Br J Dermatol; 2009 Feb; 160(2):442-5. PubMed ID: 19016696
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
14. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
15. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
Bagazgoitia L; Cuevas J; Juarranz A
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
[TBL] [Abstract][Full Text] [Related]
17. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
Hida Y; Kubo Y; Murao K; Arase S
Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
[TBL] [Abstract][Full Text] [Related]
18. Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes.
Peternel S; Manestar-Blažić T; Brajac I; Prpić-Massari L; Kaštelan M
J Cutan Pathol; 2011 Oct; 38(10):780-9. PubMed ID: 21797919
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell subsets and immunological milieu in inflammatory human papilloma virus-related skin lesions.
Nakayama Y; Asagoe K; Yamauchi A; Yamamoto T; Shirafuji Y; Morizane S; Nakanishi G; Iwatsuki K
J Dermatol Sci; 2011 Sep; 63(3):173-83. PubMed ID: 21715145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]